Activation and modulation of 72 kDa matrix metalloproteinase-2 by peroxynitrite and glutathione

• Published in: Biochemical pharmacology 2009-03, Vol.77 (5), p.826-834
• Main Authors: Viappiani, Serena, Nicolescu, Adrian C., Holt, Andrew, Sawicki, Grzegorz, Crawford, Bryan D., León, Hernando, van Mulligen, Tyler, Schulz, Richard
• Format: Article
• Language: English
• Subjects: Biological and medical sciences; Matrix metalloproteinase-2; Medical sciences; Oxidative stress; Peroxynitrite; Pharmacology. Drug treatments; S-glutathiolation; Troponin I
• ISSN: 0006-2952; 1873-2968
• DOI: 10.1016/j.bcp.2008.11.004

Matrix metalloproteinase-2 (MMP-2) has emerged as a key protease in various pathologies associated with oxidative stress, including myocardial ischemia-reperfusion, heart failure or inflammation. Peroxynitrite (ONOO −), an important effector of oxidative stress, was reported to activate some full length MMP zymogens, particularly in the presence of glutathione (GSH), but whether this occurs for MMP-2 is unknown. Treating MMP-2 zymogen with ONOO − resulted in a concentration-dependent regulation of MMP-2, with 0.3–1 μM ONOO − increasing and 30–100 μM ONOO − attenuating enzyme activity. The enzyme's V max was also significantly increased by 1 μM ONOO −. Comparable responses to ONOO − treatment were observed using the intracellular target of MMP-2, troponin I (TnI). GSH at 100 μM attenuated the effects of ONOO − on MMP-2. Mass spectrometry revealed that ONOO − can oxidize and, in the presence of GSH, S-glutathiolate the MMP-2 zymogen or a synthetic peptide containing the cysteine-switch motif in the enzyme's autoinhibitory domain. These results suggest that ONOO − and GSH can modulate the activity of 72 kDa MMP-2 by modifying the cysteine residue in the autoinhibitory domain of the zymogen, a process that may be relevant to pathophysiological conditions associated with increased oxidative stress.